B. Riley initiated coverage of Opus Genetics (IRD) with a Buy rating and $9 price target
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IRD:
- Opus announces recommendation for IDMC for Phase 1/2 trial of OPGx-BEST1
- Opus Genetics initiated with a Buy at Brookline
- Opus Genetics initiated with an Overweight at Piper Sandler
- Buy These 3 Penny Stocks Now, Say Five-Star Analysts
- Opus Genetics doses first participant in OPGx-BEST1 Phase 1/2 trial